Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes

Genes and Cancer

Volumn 1, Issue 2, 2010, Pages 115-124

  Harris, Chris R ^a,b   Normart, Robin ^a   Yang, Qifeng ^b,c,d   Stevenson, Elizabeth ^a   Haffty, Bruce G ^b,c   Ganesan, Shridar ^b   Cordon Cardo, Carlos ^e   Levine, Arnold J ^b,f   Tang, Laura H ^g  

^a The Verto Institute   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d SHANDONG UNIVERSITY   (China)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f INSTITUTE FOR ADVANCED STUDY   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancers; Line expression; Line movement

Indexed keywords

L1 ORF1 PROTEIN; LONG INTERSPERSED NUCLEAR ELEMENT 1 PROTEIN; NUCLEOLIN; ONCOPROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER TUMOR; BREAST CANCER; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOID; CELLULAR DISTRIBUTION; COLORECTAL TUMOR; CONTROLLED STUDY; DISTANT METASTASIS; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROPOSON; RNA INTERFERENCE;

EID: 79952822096     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601909360812     Document Type: Article

References (52)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
2. Babushok DV, Kazazian HH, Jr. Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat 2007;28:527-39.
3. Martin SL, Branciforte D, Keller D, Bain DL. Trimeric structure for an essential protein in L1 retrotransposition. Proc Natl Acad Sci U S A 2003;100:13815-20.
4. Martin SL, Bushman FD. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol Cell Biol 2001;21:467-75.
5. Kulpa DA, Moran JV. Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum Mol Genet 2005;14:3237-48.
6. Ostertag EM, Kazazian HH, Jr. Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res 2001;11:2059-65.
7. Ovchinnikov I, Rubin A, Swergold GD. Tracing the LINEs of human evolution. Proc Natl Acad Sci U S A 2002;99:10522-7.
8. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A 2003;100:5280-5.
9. Martin SL, Branciforte D. Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells. Mol Cell Biol 1993;13:5383-92.
10. Asch HL, Eliacin E, Fanning TG, Connolly JL, Bratthauer G, Asch BB. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues. Oncol Res 1996;8:239-47.
11. Ergun S, Buschmann C, Heukeshoven J, Dammann K, Schnieders F, Lauke H, et al. Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues. J Biol Chem 2004;279:27753-63.
12. Bratthauer GL, Fanning TG. Active LINE-1 retrotransposons in human testicular cancer. Oncogene 1992;7:507-10.
13. Bratthauer GL, Fanning TG. LINE-1 retrotransposon expression in pediatric germ cell tumors. Cancer 1993;71:2383-6.
14. Rashkova S, Karam SE, Pardue ML. Element-specific localization of Drosophila retrotransposon Gag proteins occurs in both nucleus and cytoplasm. Proc Natl Acad Sci U S A 2002;99:3621-6.
15. Kubo S, Seleme MC, Soifer HS, Perez JL, Moran JV, Kazazian HH, Jr, et al. L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci U S A 2006;103 8036-41.
16. Goodier JL, Ostertag EM, Engleka KA, Seleme MC, Kazazian HH, Jr. A potential role for the nucleolus in L1 retrotransposition. Hum Mol Genet 2004;13:1041-8.
17. Ostertag EM, Kazazian HH, Jr. Biology of mammalian L1 retrotransposons. Annu Rev Genet 2001;35:501-38.
18. Branciforte D, Martin SL. Developmental and cell type specificity of LINE-1 expression in mouse testis: implications for transposition. Mol Cell Biol 1994;14:2584-92.
19. Woodcock DM, Williamson MR, Doherty JP. A sensitive RNase protection assay to detect transcripts from potentially functional human endogenous L1 retrotransposons. Biochem Biophys Res Commun 1996;222:460-5.
20. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997;13:335-40.
21. Hata K, Sakaki Y. Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene 1997;189:227-34.
22. Thayer RE, Singer MF, Fanning TG. Undermethylation of specific LINE-1 sequences in human cells producing a LINE-1-encoded protein. Gene 1993;133:273-7.
23. Yang N, Kazazian HH, Jr. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol 2006;13:763-71.
24. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
25. Leibold DM, Swergold GD, Singer MF, Thayer RE, Dombroski BA, Fanning TG. Translation of LINE-1 DNA elements in vitro and in human cells. Proc Natl Acad Sci U S A 1990;87:6990-4.
26. Bratthauer GL, Cardiff RD, Fanning TG. Expression of LINE-1 retrotransposons in human breast cancer. Cancer 1994;73:2333-6.
27. Oberg K. Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment. Curr Opin Oncol 2002;14:38-45.
28. Vosburgh E. Neoplasms of the diffuse endocrine system. In: Kufe D, editor. Cancer medicine 7. Ontario (Canada): B.C. Decker; 2006. p. 1109-30.
29. Schulz WA. L1 retrotransposons in human cancers. J Biomed Biotechnol 2006;2006:83672.
30. Han JS, Boeke JD. LINE-1 retrotransposons: modulators of quantity and quality of mammalian gene expression? Bioessays 2005;27:775-84.
31. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol 2001;21:1973-85.
32. Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G, et al. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 2002;110:327-38.
33. Gilbert N, Lutz-Prigge S, Moran JV. Genomic deletions created upon LINE-1 retrotransposition. Cell 2002;110:315-25.
34. Alves G, Tatro A, Fanning T. Differential methylation of human LINE-1 retrotransposons in malignant cells. Gene 1996;176:39-44.
35. Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 1999;80:1312-21.
36. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, et al. Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res. Cancer Res 2001;61:4238-43.
37. Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate 1999;39:166-74.
38. Dante R, Dante-Paire J, Rigal D, Roizes G. Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors. Anticancer Res 1992;12:559-63.
39. Choi IS, Estecio MR, Nagano Y, Kim do H, White JA, Yao JC, et al. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Mod Pathol 2007;20:802-10.
40. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervante F, Sanchez J, Garate L, et al. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 2005;24:7213-23.
41. Sciamanna I, Landriscina M, Pittoggi C, Quirino M, Mearelli C, Beraldi R, et al. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 2005;24:3923-31.
42. Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 1988;333:87-90.
43. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 1992;52:643-5.
44. Han JS, Szak ST, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004;429:268-74.
45. Farkash EA, Kao GD, Horman SR, Prak ET. Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay. Nucleic Acids Res 2006;34:1196-204.
46. Park WS, Oh RR, Park JY, Kim PJ, Shin MS, Lee JH, et al. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 2001;193:483-90.
47. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 1999;59: 1811-5.
48. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997;275:1787-90.
49. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130-4.
50. Ostertag EM, Prak ET, DeBerardinis RJ, Moran JV, Kazazian HH Jr. Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res 2000;28:1418-23.
51. Evers BM, Townsend CM Jr, Upp JR, Allen E, Hurlbut SC, Kim SW, et al. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 1991;101:303-11.
52. Parikh RR, Yang Q, Higgins SA, Haffty BG. Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 Expression. Int J Radiat Oncol Biol Phys 2008;70:35-42.